- XV Eurasian Hematology-Oncology Congress - EHOC 2024
- XIV Eurasian Hematology-Oncology Congress - EHOC 2023
- 8th Eurasian Hematology Oncology Summit
- XIth Eurasian Hematology-Oncology Congress - EHOC 2020
- 7th Eurasian Hematology Oncology Summit
- Xth Eurasian Hematology-Oncology Congress
- Events
Playback speed
10 seconds
IO for R/R cHL: Optimal Treatment Regimen, Therapy Duration & Discontinuation, Prognostic Factors, Treatment Strategy in Case of Resistance
0 views
January 12, 2021
Comments 0
Login to view comments.
Click here to Login
Lymphoma